Related Experiment Video
Updated: Jan 27, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
Tumor dormancy at bedside: A late awakening.
Romano Demicheli1, Christine Desmedt2, Martine Piccart2
1Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Breast cancer can recur late, even after 5 years disease-free. Tumor dormancy, a state of microscopic metastasis quiescence, explains these late recurrences and suggests a need for tailored treatments.
Area of Science:
- Oncology
- Cancer Research
- Metastasis Research
Background:
- Breast cancer recurrence can occur years after primary treatment.
- The dynamics of recurrence events suggest phases of tumor dormancy and reactivation.
- Late recurrences (beyond 5 years) are less understood than early ones.
Purpose of the Study:
- To analyze the clinical course of late breast cancer recurrences.
- To investigate the role of tumor dormancy in late recurrence patterns.
- To support the development of targeted therapies for late recurrences.
Main Methods:
- Analysis of late clinical course data from patients disease-free at 5 years.
- Examination of recurrence patterns to identify underlying dynamics.
- Correlation of observed patterns with the tumor dormancy model.
Main Results:
- Late breast cancer recurrences exhibit a structured, multipeak pattern.
- This pattern supports the hypothesis that tumor dormancy contributes to late recurrence risk.
- The findings align with existing models explaining early recurrence dynamics.
Conclusions:
- Tumor dormancy is a significant factor in late breast cancer recurrence.
- Understanding dormancy dynamics is crucial for managing late recurrences.
- Tailored treatment strategies are necessary to address late clinical recurrences.
More Related Videos
07:03Reliable Method for Assessing Seed Germination, Dormancy, and Mortality under Field Conditions
Published on: November 6, 2016
07:25Combining Histochemical Staining and Image Analysis to Quantify Starch in the Ovary Primordia of Sweet Cherry during Winter Dormancy
Published on: March 20, 2019
Related Concept Videos
Tumor Immunotherapy
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...